Market Overview

Sterne Agee Initiates Boston Scientific At Neutral

Related BSX
Volcano Up 55% On Acquisition News
How To Profit From An Aging Population

Sterne Agee initiated coverage on shares of Boston Scientific (NYSE: BSX) with a Neutral rating.

The target price for Boston Scientific is set to $13.50.

Boston Scientific shares have surged 19.76% over the past 52 weeks, while the S&P 500 index has gained 17.38% in the same period.

Boston Scientific's shares dropped 1.07% to close at $12.97 yesterday.

Latest Ratings for BSX

DateFirmActionFromTo
Oct 2014Goldman SachsUpgradesSellNeutral
Oct 2014BenchmarkUpgradesHoldBuy
Sep 2014NeedhamInitiates Coverage onHold

View More Analyst Ratings for BSX
View the Latest Analyst Ratings

Posted-In: Sterne AgeeInitiation Analyst Ratings

 

Related Articles (BSX)

Around the Web, We're Loving...

Get Benzinga's Newsletters